4.6 Article

Neuregulin Receptor ErbB4 Functions as a Transcriptional Cofactor for the Expression of Surfactant Protein B in the Fetal Lung

Journal

Publisher

AMER THORACIC SOC
DOI: 10.1165/rcmb.2010-0179OC

Keywords

Surfactant; Type II cell; Stat5a; lung development

Funding

  1. German Research Foundation [Da 378/3-1, Da 378/3-2]
  2. National Heart, Lung, and Blood Institute from the National Institutes of Health [HL-04436]

Ask authors/readers for more resources

Sufficient pulmonary surfactant production is required for the fetal-neonatal transition, especially in preterm infants. Neuregulin (NRG) and its transmembrane receptor ErbB4 positively regulate the onset of fetal surfactant synthesis. Details of this signaling process remain to be elucidated. ErbB4 is known to regulate gene expression in the mammary gland, where the receptor associates with the signal transducer and activator of transcription Stat5a to transactivate the beta-casein gene promoter. We hypothesized that in the fetal lung, ErbB4 functions as a transcriptional regulator for surfactant protein B (Sftpb), the most critical surfactant protein gene. Re-expressing full-length ErbB4 in primary fetal ErbB4-depleted Type II epithelial cells led to an increased expression of Sftpb mRNA. This stimulatory effect required the nuclear translocation of ErbB4 and association with Stat5a, with the resultant binding to and activation of the Sftpb promoter. We conclude that ErbB4 directly regulates important aspects of fetal lung maturation that help prepare for the fetal-neonatal transition.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

Stefanie H. Mueller, Alvina G. Lai, Maria Valkovskaya, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, Joe Dennis, Michael Lush, Zomoruda Abu-Ful, Thomas U. Ahearn, Irene L. Andrulis, Hoda Anton-Culver, Natalia N. Antonenkova, Volker Arndt, Kristan J. Aronson, Annelie Augustinsson, Thais Baert, Laura E. Beane Freeman, Matthias W. Beckmann, Sabine Behrens, Javier Benitez, Marina Bermisheva, Carl Blomqvist, Natalia Bogdanova, Stig E. Bojesen, Bernardo Bonanni, Hermann Brenner, Sara Y. Brucker, Saundra S. Buys, Jose E. Castelao, Tsun L. Chan, Jenny Chang-Claude, Stephen J. Chanock, Ji-Yeob Choi, Wendy K. Chung, Sarah Colonna, Sten Cornelissen, Fergus J. Couch, Kamila Czene, Mary B. Daly, Peter Devilee, Thilo Dork, Laure Dossus, Miriam Dwek, Diana M. Eccles, Arif B. Ekici, A. Heather Eliassen, Christoph Engel, D. Gareth Evans, Peter A. Fasching, Olivia Fletcher, Henrik Flyger, Manuela Gago-Dominguez, Yu-Tang Gao, Montserrat Garcia-Closas, Jose A. Garcia-Saenz, Jeanine Genkinger, Aleksandra Gentry-Maharaj, Felix Grassmann, Pascal Guenel, Melanie Gundert, Lothar Haeberle, Eric Hahnen, Christopher A. Haiman, Niclas Hakansson, Per Hall, Elaine F. Harkness, Patricia A. Harrington, Jaana M. Hartikainen, Mikael Hartman, Alexander Hein, Weang-Kee Ho, Maartje J. Hooning, Reiner Hoppe, John L. Hopper, Richard S. Houlston, Anthony Howell, David J. Hunter, Dezheng Huo, Abctb Investigators, Hidemi Ito, Motoki Iwasaki, Anna Jakubowska, Wolfgang Janni, Esther M. John, Michael E. Jones, Audrey Jung, Rudolf Kaaks, Daehee Kang, Elza K. Khusnutdinova, Sung-Won Kim, Cari M. Kitahara, Stella Koutros, Peter Kraft, Vessela N. Kristensen, Katerina Kubelka-Sabit, Allison W. Kurian, Ava Kwong, James Lacey, Diether Lambrechts, Loic Le Marchand, Jingmei Li, Martha Linet, Wing-Yee Lo, Jirong Long, Artitaya Lophatananon, Arto Mannermaa, Mehdi Manoochehri, Sara Margolin, Keitaro Matsuo, Dimitrios Mavroudis, Usha Menon, Kenneth Muir, Rachel A. Murphy, Heli Nevanlinna, William G. Newman, Dieter Niederacher, Katie M. O'Brien, Nadia Obi, Kenneth Offit, Olufunmilayo Olopade, Andrew F. Olshan, Hakan Olsson, Sue K. Park, Alpa Patel, Achal Patel, Charles M. Perou, Julian Peto, Paul D. P. Pharoah, Dijana Plaseska-Karanfilska, Nadege Presneau, Brigitte Rack, Paolo Radice, Dhanya Ramachandran, Muhammad U. Rashid, Gad Rennert, Atocha Romero, Kathryn J. Ruddy, Matthias Ruebner, Emmanouil Saloustros, Dale P. Sandler, Elinor J. Sawyer, Marjanka K. Schmidt, Rita K. Schmutzler, Michael O. Schneider, Christopher Scott, Mitul Shah, Priyanka Sharma, Chen-Yang Shen, Xiao-Ou Shu, Jacques Simard, Harald Surowy, Rulla M. Tamimi, William J. Tapper, Jack A. Taylor, Soo Hwang Teo, Lauren R. Teras, Amanda E. Toland, Rob A. E. M. Tollenaar, Diana Torres, Gabriela Torres-Mejia, Melissa A. Troester, Therese Truong, Celine M. Vachon, Joseph Vijai, Clarice R. Weinberg, Camilla Wendt, Robert Winqvist, Alicja Wolk, Anna H. Wu, Taiki Yamaji, Xiaohong R. Yang, Jyh-Cherng Yu, Wei Zheng, Argyrios Ziogas, Elad Ziv, Alison M. Dunning, Douglas F. Easton, Harry Hemingway, Ute Hamann, Karoline B. Kuchenbaecker

Summary: This study identified 14 genes associated with breast cancer using gene-based aggregation analysis, including two newly discovered genes FMNL3 and AC058822.1. Furthermore, associations with established candidate genes like ESR1 were found through the collaboration of multi-ancestral cohorts, highlighting the importance of diversifying study cohorts. These findings provide new insights into the development of breast cancer.

GENOME MEDICINE (2023)

Article Pediatrics

Polymorphisms of the hypothalamic-pituitary-adrenal axis may lead to an inadequate response to stress and contribute to sudden infant death syndrome

Elanur Uzuntas, Peter Schuermann, Thomas Rothaemel, Thilo Doerk, Michael Klintschar

Summary: The study found that single nucleotide polymorphisms relevant to the hypothalamic-pituitary-adrenal (HPA) axis, which regulates the stress hormone cortisol, are associated with sudden infant death syndrome (SIDS). These variants appear to decrease cortisol concentration and impair stress response.

ACTA PAEDIATRICA (2023)

Article Oncology

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

Denise G. O'Mahony, Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John, Ute Hamann, Evgeny N. Imyanitov, Irene L. Andrulis, Priyanka Sharma, Mary B. Daly, Christopher R. Hake, Jeffrey N. Weitzel, Anna Jakubowska, Andrew K. Godwin, Adalgeir Arason, Anita Bane, Jacques Simard, Penny Soucy, Maria A. Caligo, Phuong L. Mai, Kathleen B. M. Claes, Manuel R. Teixeira, Wendy K. Chung, Conxi Lazaro, Peter J. Hulick, Amanda E. Toland, Inge Sokilde Pedersen, Susan L. Neuhausen, Ana Vega, Miguel de la Hoya, Heli Nevanlinna, Mallika Dhawan, Valentina Zampiga, Rita Danesi, Liliana Varesco, Viviana Gismondi, Valerio Gaetano Vellone, Paul A. James, Ramunas Janavicius, Liene Nikitina-Zake, Finn Cilius Nielsen, Thomas van Overeem Hansen, Tanja Pejovic, Ake Borg, Johanna Rantala, Kenneth Offit, Marco Montagna, Katherine L. Nathanson, Susan M. Domchek, Ana Osorio, Maria J. Garcia, Beth Y. Karlan, Anna De Fazio, David Bowtell, Lesley McGuffog, Goska Leslie, Michael T. Parsons, Thilo Doerk, Lisa-Marie Speith, Elizabeth Santana dos Santos, Alexandre Andre B. A. da Costa, Paolo Radice, Paolo Peterlongo, Laura Papi, Christoph Engel, Eric Hahnen, Rita K. Schmutzler, Barbara Wappenschmidt, Douglas F. Easton, Marc Tischkowitz, Christian F. Singer, Yen Yen Tan, Alice S. Whittemore, Weiva Sieh, James D. Brenton, Drakoulis Yannoukakos, Florentia Fostira, Irene Konstantopoulou, Jana Soukupova, Michal Vocka, Georgia Chenevix-Trench, Paul D. P. Pharoah, Antonis C. Antoniou, David E. Goldgar, Amanda B. Spurdle, Kyriaki Michailidou, Marian J. E. Mourits, Fabienne Lesueur

Summary: This study assessed the utility of ovarian tumour characteristics as predictors of BRCA1 and BRCA2 variant pathogenicity and provided evidence for improved classification and clinical management of carriers.

BRITISH JOURNAL OF CANCER (2023)

Article Biochemistry & Molecular Biology

CLEC12A Binds to Legionella pneumophila but Has No Impact on the Host's Antibacterial Response

Ann-Brit Klatt, Christina Diersing, Juliane Lippmann, Sabine Mayer-Lambertz, Felix Stegmann, Swantje Fischer, Sandra Caesar, Facundo Fiocca Vernengo, Katja Hoenzke, Andreas C. Hocke, Juergen Ruland, Martin Witzenrath, Bernd Lepenies, Bastian Opitz

Summary: CLEC12A can bind to Legionella pneumophila-derived ligands, but it does not play a major role in the innate defense against the bacterium.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions

Sara Lindstrom, Lu Wang, Helian Feng, Arunabha Majumdar, Sijia Huo, James Macdonald, Tabitha Harrison, Constance Turman, Hongjie Chen, Nicholas Mancuso, Theo Bammler, Steve Gallinger, Stephen B. Gruber, Marc J. Gunter, Loic Le Marchand, Victor Moreno, Kenneth Offit, Immaculata De Vivo, Tracy A. O'Mara, Amanda B. Spurdle, Ian Tomlinson, Rebecca Fitzgerald, Puya Gharahkhani, Ines Gockel, Janusz Jankowski, Stuart Macgregor, Johannes Schumacher, Jill Barnholtz-Sloan, Melissa L. Bondy, Richard S. Houlston, Robert B. Jenkins, Beatrice Melin, Margaret Wrensch, Paul Brennan, David C. Christiani, Mattias Johansson, James Mckay, Melinda C. Aldrich, Christopher Amos, Maria Teresa Landi, Adonina Tardon, D. Timothy Bishop, Florence Demenais, Alisa M. Goldstein, Mark M. Iles, Peter A. Kanetsky, Matthew H. Law, Laufey T. Amundadottir, Rachael Stolzenberg-Solomon, Brian M. Wolpin, Alison Klein, Gloria Petersen, Harvey Risch, Stephen J. Chanock, Mark P. Purdue, Ghislaine Scelo, Paul Pharoah, Siddhartha Kar, Rayjean J. Hung, Bogdan Pasaniuc, Peter Kraft

Summary: This study quantified the shared genetic contribution to risk of different cancers and identified novel cancer susceptibility loci using data from 12 cancer genome-wide association studies. The results suggest that some genetic risk variants are shared among cancers, but most of cancer heritability is specific to certain tissues. Cross-disease analysis allows for increased statistical power and the identification of new susceptibility regions. Future studies are likely to discover additional regions associated with the risk of multiple cancer types.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Chemistry, Multidisciplinary

Dual-Action Heteromultivalent Glycopolymers Stringently Block and Arrest Influenza A Virus Infection In Vitro and Ex Vivo

Badri Parshad, Marlena N. Schlecht, Morris Baumgardt, Kai Ludwig, Chuanxiong Nie, Agustina Rimondi, Katja Honzke, Stefano Angioletti-Uberti, Vinod Khatri, Paul Schneider, Andreas Herrmann, Rainer Haag, Andreas C. Hocke, Thorsten Wolff, Sumati Bhatia

Summary: In this study, a low-molecular-weight dual-action linear polymer is used to successfully inhibit different strains of influenza A virus. The optimized polymer targets both hemagglutinin and neuraminidase on the virus surface, leading to effective inhibition of virus propagation. The polymer is significantly more effective than the commercial drug zanamivir, demonstrating its translational potential for broad and high antiviral efficacy.

NANO LETTERS (2023)

Article Reproductive Biology

Targeted next-generation sequencing of 21 candidate genes in hereditary ovarian cancer patients from the Republic of Bashkortostan

D. S. Prokofyeva, E. T. Mingazheva, Ya. V. Valova, D. D. Sakaeva, R. R. Faishanova, A. Kh. Nurgalieva, R. R. Valiev, N. Bogdanova, T. Doerk, E. K. Khusnutdinova

Summary: Around 5-10% of ovarian cancer cases have a familial pattern, with 15-25% of these cases being caused by high-risk mutations in the BRCA1 and BRCA2 genes. This study aimed to identify other genes associated with familial ovarian cancer by sequencing 21 candidate genes in DNA samples from 48 patients in the Republic of Bashkortostan. Deleterious variants in BRCA1, BRCA2, CHEK2, MSH6, and NBN were found in 16 patients (33%), including a previously unreported NBN truncating variant. The panel of genes analyzed explains approximately one-third of the familial ovarian cancer risk in this region.

JOURNAL OF OVARIAN RESEARCH (2023)

Article Multidisciplinary Sciences

Multi-trait genome-wide association study identifies a novel endometrial cancer risk locus that associates with testosterone levels

Xuemin Wang, Pik Fang Kho, Dhanya Ramachandran, Cemsel Bafligil, Frederic Amant, Ellen L. Goode, Rodney J. Scott, Ian Tomlinson, D. Gareth Evans, Emma J. Crobie, Thilo Doerk, Amanda B. Spurdle, Dylan M. Clubb, Tracy A. O'Mara

Summary: By analyzing multiple endometrial cancer risk factors using a multi-trait GWAS analysis, we identified three potentially novel loci associated with endometrial cancer risk. One of these loci (7q22.1) was replicated in an independent endometrial cancer GWAS dataset and reached genome-wide significance in a meta-analysis. This locus may influence endometrial cancer risk through altered testosterone levels, as indicated by the colocalization between risk signals and expression of the testosterone metabolism gene CYP3A7. Our findings suggest potential opportunities for hormone therapy in the prevention or treatment of endometrial cancer.

ISCIENCE (2023)

Article Surgery

Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis

Taymaa May, Marcus Bernardini, Stephanie Lheureux, Katja K. H. Aben, Elisa V. Bandera, Matthias W. Beckmann, Javier Benitez, Andrew Berchuck, Line Bjorge, Michael E. Carney, Daniel W. Cramer, Anna deFazio, Thilo Doerk, Diana M. Eccles, Michael Friedlander, Maria Jose Garcia, Ellen L. Goode, Alexander Hein, Claus K. Hogdall, Allan Jensen, Sharon Johnatty, Catherine J. Kennedy, Lambertus A. Kiemeney, Susanne K. Kjaer, Jolanta Kupryjanczyk, Keitaro Matsuo, Valerie McGuire, Francesmary Modugno, Lisa E. Paddock, Tanja Pejovic, Catherine M. Phelan, Marjorie J. Riggan, Cristina Rodriguez-Antona, Joseph H. Rothstein, Weiva Sieh, Honglin Song, Kathryn L. Terry, Anne M. van Altena, Adriaan Vanderstichele, Ignace Vergote, Liv Cecilie Vestrheim Thomsen, Penelope M. Webb, Nicolas Wentzensen, Lynne R. Wilkens, Argyrios Ziogas, Haiyan Jiang, Alicia Tone

Summary: This study analyzed the factors affecting survival in patients with low-grade ovarian serous carcinoma. The results showed that complete surgical cytoreduction has the most impact on improved survival, while the role of chemotherapy is still controversial.

CANADIAN JOURNAL OF SURGERY (2023)

Article Immunology

Bone Marrow Failure and Immunodeficiency Associated with Human RAD50 Variants

Masatoshi Takagi, Akihiro Hoshino, Kristine Bousset, Jule Roeddecke, Hanna Luisa Martin, Iulia Folcut, Dan Tomomasa, Xi Yang, Junya Kobayashi, Naoki Sakata, Kenichi Yoshida, Satoru Miyano, Seishi Ogawa, Seiji Kojima, Tomohiro Morio, Thilo Doerk, Hirokazu Kanegane

Summary: This study describes a newly identified RAD50 deficiency/NBS-like disorder (NBSLD) patient characterized by bone marrow failure and B-cell immunodeficiency. Compound heterozygosity for two variants in the RAD50 gene (p.Arg83His and p.Glu485Ter) was found in this patient. These findings highlight the important roles of RAD50 in human bone marrow and immune cells.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Article Genetics & Heredity

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

Hagai Levi, Shai Carmi, Saharon Rosset, Rinat Yerushalmi, Aviad Zick, Tamar Yablonski-Peretz, Qin Wang, Manjeet K. Bolla, Joe Dennis, Kyriaki Michailidou, Michael Lush, Thomas Ahearn, Irene L. Andrulis, Hoda Anton-Culver, Antonis C. Antoniou, Volker Arndt, Annelie Augustinsson, Paivi Auvinen, Laura Beane Freeman, Matthias Beckmann, Sabine Behrens, Marina Bermisheva, Clara Bodelon, Natalia Bogdanova, Stig E. Bojesen, Hermann Brenner, Helen Byers, Nicola Camp, Jose Castelao, Jenny Chang-Claude, Maria-Dolores Chirlaque, Wendy Chung, Christine Clarke, Margriet J. Collee, Sarah Colonna, Fergus Couch, Angela Cox, Simon S. Cross, Kamila Czene, Mary Daly, Peter Devilee, Thilo Dork, Laure Dossus, Diana M. Eccles, A. Heather Eliassen, Mikael Eriksson, Gareth Evans, Peter Fasching, Olivia Fletcher, Henrik Flyger, Lin Fritschi, Marike Gabrielson, Manuela Gago-Dominguez, Montserrat Garcia-Closas, Jose Angel Garcia-Saenz, Jeanine Genkinger, Graham G. Giles, Mark Goldberg, Pascal Guenel, Per Hall, Ute Hamann, Wei He, Peter Hillemanns, Antoinette Hollestelle, Reiner Hoppe, John Hopper, Simona Jakovchevska, Anna Jakubowska, Helena Jernstrom, Esther John, Nichola Johnson, Michael Jones, Joseph Vijai, Rudolf Kaaks, Elza Khusnutdinova, Cari Kitahara, Stella Koutros, Vessela Kristensen, Allison W. Kurian, James Lacey, Diether Lambrechts, Loic Le Marchand, Flavio Lejbkowicz, Annika Lindblom, Sibylle Loibl, Adriana Lori, Jan Lubinski, Arto Mannermaa, Mehdi Manoochehri, Dimitrios Mavroudis, Usha Menon, AnnaMarie Mulligan, Rachel Murphy, Ines Nevelsteen, William G. Newman, Nadia Obi, Katie O'Brien, Ken Offit, Andrew Olshan, Dijana Plaseska-Karanfilska, Janet Olson, Salvatore Panico, Tjoung-Won Park-Simon, Alpa Patel, Paolo Peterlongo, Brigitte Rack, Paolo Radice, Gad Rennert, Valerie Rhenius, Atocha Romero, Emmanouil Saloustros, Dale Sandler, Marjanka K. Schmidt, Lukas Schwentner, Mitul Shah, Priyanka Sharma, Jacques Simard, Melissa Southey, Jennifer Stone, William J. Tapper, Jack Taylor, Lauren Teras, Amanda E. Toland, Melissa Troester, Therese Truong, Lizet E. van der Kolk, Clarice Weinberg, Camilla Wendt, Xiaohong Rose Yang, Wei Zheng, Argyrios Ziogas, Alison M. Dunning, Paul Pharoah, Douglas F. Easton, Shay Ben-Sachar, Naama Elefant, Ron Shamir, Ran Elkon

Summary: This study examined the performance of European-based breast cancer (BC) polygenic risk score (PRS) models in Ashkenazi Jewish (AJ) women. The results showed that the European-based PRS models can identify AJ women with significantly increased BC risk, offering potential improvement in BC risk assessment for this population.

JOURNAL OF MEDICAL GENETICS (2023)

Article Oncology

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival

Anna Morra, Maartje A. C. Schreurs, Irene L. Andrulis, Hoda Anton-Culver, Annelie Augustinsson, Matthias W. Beckmann, Sabine Behrens, Stig E. Bojesen, Manjeet K. Bolla, Hiltrud Brauch, Annegien Broeks, Saundra S. Buys, Nicola J. Camp, Jose E. Castelao, Melissa H. Cessna, Jenny Chang-Claude, Wendy K. Chung, Sarah Colonna, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Mary B. Daly, Joe Dennis, Peter Devilee, Thilo Doerk, Alison M. Dunning, Miriam Dwek, Douglas F. Easton, Diana M. Eccles, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Tanja N. Fehm, Jonine D. Figueroa, Henrik Flyger, Marike Gabrielson, Manuela Gago-Dominguez, Montserrat Garcia-Closas, Jose A. Garcia-Saenz, Jeanine A. Genkinger, Felix Grassmann, Melanie Guendert, Eric Hahnen, Christopher Haiman, Ute Hamann, Patricia A. Harrington, Jaana M. Hartikainen, Reiner Hoppe, John L. Hopper, Richard S. Houlston, Anthony Howell, Anna Jakubowska, Wolfgang Janni, Helena Jernstroem, Esther M. John, Nichola Johnson, Michael E. Jones, Vessela N. Kristensen, Allison Kurian, Diether Lambrechts, Loic Le Marchand, Annika Lindblom, Jan Lubinski, Michael P. Lux, Arto Mannermaa, Dimitrios Mavroudis, Anna Marie Mulligan, Taru A. Muranen, Heli Nevanlinna, Ines Nevelsteen, Patrick Neven, William G. Newman, Nadia Obi, Kenneth Offit, Andrew F. Olshan, Tjoung-Won Park-Simon, Alpa Patel, Paolo Peterlongo, Kelly-Anne Phillips, Dijana Plaseska-Karanfilska, Eric C. Polley, Nadege Presneau, Katri Pylkas, Brigitte Rack, Paolo Radice, Muhammad U. Rashid, Valerie Rhenius, Mark Robson, Atocha Romero, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Sabine Schuetze, Christopher Scott, Mitul T. Shah, Snezhana Smichkoska, Melissa C. Southey, William J. Tapper, Lauren R. Teras, Rob A. E. M. Tollenaar, Katarzyna Tomczyk, Ian Tomlinson, Melissa Troester, Celine Vachon, Elke van Veen, Qin Wang, Camilla Wendt, Hans Wildiers, Robert A. Winqvist, Argyrios Ziogas, Per Hall, Paul D. P. Pharoah, Muriel Adank, Antoinette Hollestelle, Marjanka K. Schmidt, Maartje Hooning

Summary: Breast cancer patients with the CHEK2 c.1100delC variant have an increased risk of contralateral breast cancer and worse survival. Systemic therapy is associated with reduced contralateral breast cancer risk, regardless of CHEK2 c.1100delC status. Patients with the CHEK2 c.1100delC variant have shorter survival, which is not fully explained by their contralateral breast cancer risk.

CANCER MEDICINE (2023)

Article Oncology

Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

Gisella Figlioli, Amandine K. Billaud, Qin Wang, Manjeet Bolla, Joe Dennis, Michael A. Lush, Anders U. Kvist, Muriel N. Adank, Thomas Ahearn, Natalia Antonenkova, Paeivi Auvinen, Sabine V. Behrens, Marina E. Bermisheva, Natalia Bogdanova, Stig Bojesen, Bernardo J. Bonanni, Thomas Bruening, Nicola E. Camp, Archie H. Campbell, Jose Castelao, Melissa Cessna, Kamila NBCS Collaborators, Kamila Czene, Peter A. Devilee, Thilo Doerk, Mikael Eriksson, Peter Fasching, Henrik Flyger, Marike Gabrielson, Manuela B. Gago-Dominguez, Montserrat Garcia-Closas, Gord Glendon, Encarna Gomez Garcia, Anna Gonzalez-Neira, Felix Grassmann, Pascal Guenel, Eric J. Hahnen, Ute Hamann, Peter Hillemanns, Maartje Hooning, Reiner Hoppe, Anthony K. Howell, Keith N. Humphreys, Elza kConFab Investigators, Anna A. Jakubowska, Elza Khusnutdinova, Vessela Kristensen, Annika Lindblom, Maria Loizidou, Jan G. Lubinski, Arto Mannermaa, Tabea I. Maurer, Dimitrios Mavroudis, William U. Newman, Nadia Obi, Mihalis Panayiotidis, Paolo Radice, Muhammad J. Rashid, Valerie K. Rhenius, Matthias K. Ruebner, Emmanouil Saloustros, Elinor C. Sawyer, Marjanka Schmidt, Rita Schmutzler, Mitul M. Shah, Melissa Southey, Ian R. Tomlinson, Therese Truong, Elke M. van Veen, Camilla Wendt, Xiaohong F. Yang, Kyriaki L. Michailidou, Alison Dunning, Paul D. P. Pharoah, Douglas Easton, Irene L. Andrulis, D. Gareth Evans, Antoinette Hollestelle, Jenny Chang-Claude, Roger Milne, Paolo Peterlongo

Summary: This study describes the geographic distribution of different FANCM mutations in breast cancer cases from Europe, USA, Canada, and Australia. The study found that certain FANCM mutations are more common in specific regions, such as FANCM:p.Gln1701* in Northern Europe and FANCM:p.Gly1906Alafs*12 in Southern Europe. These findings are important for developing efficient genetic testing strategies for specific populations.

CANCERS (2023)

Article Virology

Association of two genomic variants with HPV type-specific risk of cervical cancer

Finja Seifert, Rieke Eisenblatter, Julia Beckmann, Peter Schuermann, Patricia Hanel, Matthias Jentschke, Gerd Bohmer, Hans-Georg Strauss, Christine Hirchenhain, Monika Schmidmayr, Florian Mueller, Peter Fasching, Alexander Luyten, Norman Hafner, Matthias Duerst, Ingo B. Runnebaum, Peter Hillemanns, Thilo Dork, Dhanya Ramachandran

Summary: This study found that rs9357152 was associated with HPV16-positive cervical cancer and rs4243652 was associated with HPV18-positive adenocarcinomas. Additionally, rs9357152 was found to regulate the expression of HLA-DRB1 in HPV-positive cervical tissues.

TUMOUR VIRUS RESEARCH (2023)

Article Genetics & Heredity

A Novel Alu Element Insertion in ATM Induces Exon Skipping in Suspected HBOC Patients

Janin Klein, Aldrige B. B. Allister, Gunnar Schmidt, Annette Otto, Kai Heinecke, Jordis Bax-Knoche, Carmela Beger, Sarah Becker, Stephan Bartels, Tim Ripperger, Jens Bohne, Thilo Doerk, Brigitte Schlegelberger, Winfried Hofmann, Doris Steinemann

Summary: A novel Alu element insertion in ATM intron 54 (ATM:c.8010+30_8010+31insAluYa5) was identified as a potential contributing factor in hereditary breast and/or ovarian cancer (HBOC) patients. Experimental evidence suggested that this insertion caused exon skipping in the ATM gene. Further epidemiological and functional analyses are needed to clarify the role of ATM:c.8010+30_8010+31insAluYa5 in carcinogenesis.

HUMAN MUTATION (2023)

No Data Available